Avantax Planning Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$886K Buy
2,227
+200
+10% +$87.4K 0.02% 208
2026
Q1
$934K Buy
2,027
+77
+4% +$39K 0.03% 203
2025
Q4
$1.1M Buy
1,950
+82
+4% +$43.7K 0.03% 183
2025
Q3
$835K Buy
1,868
+423
+29% +$203K 0.02% 213
2025
Q2
$785K Buy
1,445
+293
+25% +$153K 0.02% 212
2025
Q1
$571K Buy
1,152
+101
+10% +$55.9K 0.02% 236
2024
Q4
$549K Buy
1,051
+89
+9% +$46.4K 0.02% 244
2024
Q3
$473K Sell
962
-1,103
-53% -$514K 0.02% 267
2024
Q2
$919K Buy
2,065
+286
+16% +$114K 0.03% 216
2024
Q1
$710K Buy
1,779
+292
+20% +$110K 0.02% 246
2023
Q4
$502K Buy
1,487
+123
+9% +$36.7K 0.02% 237
2023
Q3
$399K Buy
+1,364
New +$426K 0.02% 250
2018
Q2
Sell
-171
Closed -$23K 834
2018
Q1
$23K Buy
+171
New +$23.9K ﹤0.01% 727

Other funds holding ISRG

Avantax Planning Partners's ISRG Position: Q2 2026 in Review

Avantax Planning Partners increased its Intuitive Surgical (ISRG) stake by 9.9% in Q2 2026, buying an estimated $87.4K and bringing the position to 2,227 shares worth $886K. The position accounts for 0.02% of the portfolio, ranked #208.

Avantax Planning Partners first reported a position in ISRG in Q1 2018 and has held it in 13 quarters since. The position peaked at $1.1M in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Avantax Planning Partners held 2,227 shares of Intuitive Surgical worth $886K as of Q2 2026.
  • Avantax Planning Partners bought 200 Intuitive Surgical shares in Q2 2026, an estimated $87.4K.
  • Intuitive Surgical made up 0.02% of Avantax Planning Partners's portfolio in Q2 2026, its #208 holding.
  • Avantax Planning Partners first reported a position in Intuitive Surgical in Q1 2018 and has held it in 13 quarters since.
  • Avantax Planning Partners's Intuitive Surgical position peaked at $1.1M in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Avantax Planning Partners's 13F filing for Q2 2026, filed 28 Jul 2026.